Windtree Therapeutics Statistics
Share Statistics
Windtree Therapeutics has 3.66M
shares outstanding. The number of shares has increased by -0.03%
in one year.
| Shares Outstanding | 3.66M |
| Shares Change (YoY) | -0.03% |
| Shares Change (QoQ) | 0.07% |
| Owned by Institutions (%) | 0% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | n/a |
| FTD / Avg. Volume | n/a |
Short Selling Information
The latest short interest is 106.81K, so 2.92% of the outstanding
shares have been sold short.
| Short Interest | 106.81K |
| Short % of Shares Out | 2.92% |
| Short % of Float | 2.92% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -0.17 and the forward
PE ratio is null.
Windtree Therapeutics's PEG ratio is
0.
| PE Ratio | -0.17 |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | n/a |
| PB Ratio | 0.09 |
| P/FCF Ratio | -0.06 |
| PEG Ratio | 0 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Windtree Therapeutics.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.45,
with a Debt / Equity ratio of 0.18.
| Current Ratio | 0.45 |
| Quick Ratio | 0.45 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.12 |
| Interest Coverage | -106.46 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-391,928.57 |
| Employee Count | 14 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 3.69M |
| Effective Tax Rate | -206.02% |
Stock Price Statistics
The stock price has increased by null% in the
last 52 weeks. The beta is 0.82, so Windtree Therapeutics's
price volatility has been higher than the market average.
| Beta | 0.82 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 1.09 |
| 200-Day Moving Average | 58.83 |
| Relative Strength Index (RSI) | 36.48 |
| Average Volume (20 Days) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -25.02M |
| Net Income | -5.49M |
| EBITDA | n/a |
| EBIT | -1.56M |
| Earnings Per Share (EPS) | -104.35 |
Full Income StatementBalance Sheet
The company has 1.78M in cash and 1.82M in
debt, giving a net cash position of -43K.
| Cash & Cash Equivalents | 1.78M |
| Total Debt | 1.82M |
| Net Cash | -43K |
| Retained Earnings | -846.61M |
| Total Assets | 26.77M |
| Working Capital | -4.88M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -15.4M
and capital expenditures -12K, giving a free cash flow of -15.41M.
| Operating Cash Flow | -15.4M |
| Capital Expenditures | -12K |
| Free Cash Flow | -15.41M |
| FCF Per Share | -293.14 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
